Fibromyalgia Research Grants
Fibromyalgia Research Grants support investigators studying treatments, biological mechanisms, and clinical diagnostic measures to improve the lives of people with primary fibromyalgia.
Browse similar grants
Funder: American Fibromyalgia Syndrome Association
Due Dates: December 15, 2026 (Optional LOI) | March 1, 2027 (Application) | July 31, 2027 (Funding decisions)
Funding Amounts: Five grants up to $90,000 each for one to two years; total allocation up to $465,000 (U.S. dollars)
Summary: Supports clinically focused, hypothesis-driven research on fibromyalgia treatments, biological mechanisms, and clinical diagnostic measures.
Key Information: Every study team must include a clinician who will assess all participants.
Description
The American Fibromyalgia Syndrome Association (AFSA) funds clinically focused research directly relevant to people with primary fibromyalgia. Its priorities are testing therapeutic interventions or agents that reduce key symptoms, investigating peripheral and central biological mechanisms, and developing diagnostic measures suitable for clinical use. Diagnostic research should preferably use blood or other easily accessible biofluids. Projects ideally have the potential to improve patients’ lives within ten years.
Awards support direct research expenses, particularly preliminary data collection that can help investigators secure larger grants from the NIH or similar agencies. AFSA also considers clearly defined, hypothesis-driven additions to government-sponsored studies. Most of its revenue comes from people with fibromyalgia and their supporters, making patient relevance central to its funding decisions.
